aNeuroscience Research Center, Institute of Neuropharmacology

bPhysiology Research Center, Institute of Basic and Clinical Physiology Sciences

cPharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Science, Kerman, Iran

Received 17 August 2022 Accepted as revised 1 June 2023.

Correspondence to Meysam Ahmadi-Zeidabadi, PhD, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Science, Kerman, 7619813159 Iran, e-mail: [email protected], [email protected]